Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 64 Head and Neck Neoplasms 63 Squamous Cell Carcinoma of Head and Neck 60 Carcinoma, Non-Small-Cell Lung 34 Rectal Neoplasms 23 Colonic Neoplasms 23 Neoplasm Metastasis 19 Neoplasms 18 Carcinoma, Squamous Cell 17 Pancreatic Neoplasms 13 Lung Neoplasms 13 Esophageal Neoplasms 11 Tongue Neoplasms 9 Stomach Neoplasms 9 Recurrence 9 Carcinoma 8 Neoplasms, Squamous Cell 6 Mouth Neoplasms 6 Laryngeal Neoplasms 6 Breast Neoplasms 6 Adenocarcinoma Of Esophagus 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Esophageal Squamous Cell Carcinoma 5 Adenocarcinoma of Lung 5 Sarcoma 4 Salivary Gland Neoplasms 4 Oropharyngeal Neoplasms 4 Laryngeal Diseases 4 Precancerous Conditions 3 Hypopharyngeal Neoplasms 3

Interventions

Cisplatin 4 pembrolizumab 3 Nivolumab 3 Fluorouracil 2 Carboplatin 2 toripalimab 1 spartalizumab 1 fludarabine phosphate 1 fludarabine 1 cc-486 1 camrelizumab 1 Vorinostat 1 Valganciclovir 1 Range of Motion, Articular 1 Radiotherapy 1 Radiosurgery 1 Protons 1 Platinum 1 Methylprednisolone 1 Medicare Part B 1 Laryngoscopes 1 Gemcitabine 1 Docetaxel 1 Cyclophosphamide 1 Cetuximab 1 Bevacizumab 1 Azacitidine 1 Adrenal Cortex Hormones 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Carcinoma × Cetuximab × Clear all

NCT00700440 2010-03-26

ENCORE

Sun Yat-sen University

Phase 2 Completed

100 enrolled 4 charts

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡